Le Lézard
Classified in: Health
Subjects: LAW, PSF

Pritzker Hageman Legionnaires' Disease Law Firm Files First Lawsuit in North Carolina Mountain State Fair Hot Tub Legionnaires' Outbreak


ASHVILLE, N.C., Oct. 17, 2019 /PRNewswire/ -- National Legionnaires' disease law firm, Pritzker Hageman, P.A., along with local counsel Ralph W. Meekins, today filed the first Legionnaires' disease lawsuit stemming from the Legionnaires' outbreak associated with the Davis Event Center at the Mountain State Fair in Fletcher, North Carolina. The lawsuit was filed in the General Court of Justice Superior Court Division against defendants All Pro Billiards and Spa, Soft Fun LLC (doing business as SCM Relaxation) and parties that are being named as John Does until such time as identities are determined. A copy of the lawsuit is available upon request.

On September 23, 2019, the Buncombe County Department of Health and Human Services and Henderson County Health Department notified the North Carolina Division of Public Health (NCDPH) of an increase in reported Legionnaires' disease cases that, upon investigation were found to be linked to the fair. Legionnaires' disease is caused by aerosolized water droplets (spray, mist or vapor) contaminated with the Legionella bacteria. Legionella bacteria grows best in warm water between 90 and 106 degrees that has not been properly sanitized or treated for bacterial growth. It is not spread by person-to-person contact. Subsequent investigation by the NCDPH revealed that individuals who were sickened at the fair were much more likely to have spent significant time in the Davis Event Center, where a hot tub exhibit was taking place, and to have reported walking by or spending time by the hot tubs on display.

Legionnaires' disease causes an extremely dangerous form of pneumonia that often leads to hospitalization and life-long debilitating injury, and can lead to death. As of October 16, 2019, 140 people with Legionnaires' disease have been linked to this outbreak, including our client, and 3 people have died.

Pritzker Hageman, P.A. is a national Legionnaires' disease, food safety and bacterial disease law firm that represents clients who have been sickened by contaminated water and food. Pritzker Hageman's Legionnaires' lawyers, including attorneys Fred Pritzker, Eric Hageman, David Coyle and Tariq Miller, have won hundreds of millions of dollars for clients throughout the United States.

CONTACTS

Pritzker Hageman, P.A.
1-888-377-8900

Fred Pritzker
[email protected]

Eric Hageman
[email protected]

David Coyle
[email protected]

Tariq Miller
[email protected]

 

SOURCE Pritzker Hageman, P.A.


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: